Breast cancer was included in class C, as reflected in amplifications of the MYC oncogene, CCND1 and PIK3CA, deletion of CDK2NA, and inactivating mutations in TP53 leading to copy-number instability. The gene discussed is TP53; the disease is breast carcinoma.